FDA
label_change
· 2017-03-23
FDA Approved: TRILEPTAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
Summary
The FDA approved a supplemental application for TRILEPTAL (oxcarbazepine) from Novartis Pharmaceuticals Corporation, resulting in a labeling update. The snippet…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRILEPTAL (OXCARBAZEPINE)